Patrick J. Kerins, 10% Owner at Adaptimmune Therapeutics PLC (ADAP), bought 3,000,000 shares at $1.67 ($5.0M) on 2018-09-07, disclosed to the SEC on 2018-09-10.
Open-market purchase of $5.0M ADAP by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| Filing → |
| BZFD | SELL | 2025-03-06 | $45K | — | Filing → |
| SGMT | BUY | 2023-07-20 | $480K | — | Filing → |
| SGMT | SELL | 2023-07-20 | $11K | — | Filing → |